Table 1 Baseline characteristics according to high thrombotic risk features

Age, yrs

59.21 ± 10.27

57.64 ± 10.19

< 0.001

 Age ≥ 75 years

338 (7.6)

293 (5.1)

< 0.001

Male

3396 (76.7)

4445 (77.5)

0.329

Body mass index, kg/m²

26.04 ± 3.17

25.84 ± 3.19

0.002

Hypertension

3027 (68.3)

3514 (61.3)

< 0.001

Diabetes mellitus

2073 (46.8)

969 (16.9)

< 0.001

Hyperlipidemia

3042 (68.7)

3795 (66.1)

0.007

eGFR

92.48 ± 20.66

97.06 ± 16.37

< 0.001

 Moderate CKD (eGFR ≥ 30, < 60 ml/min/1.73m²)

353 (8.0)

0 (0.0)

< 0.001

 Severe CKD (eGFR < 30 ml/min/1.73m²)

7 (0.2)

0 (0.0)

0.003

Current smoker

2509 (56.6)

3305 (57.6)

0.326

Previous myocardial infarction

940 (21.2)

980 (17.1)

< 0.001

Previous PCI

1007 (22.7)

1414 (24.6)

0.025

Previous CABG

219 (4.9)

184 (3.2)

< 0.001

Previous stroke

553 (12.5)

527 (9.2)

< 0.001

Peripheral arterial disease

147 (3.3)

120 (2.1)

< 0.001

LVEF, %

62.37 ± 7.54

63.20 ± 6.97

<  0.001

Stable CAD

1905 (43.0)

2168 (37.8)

< 0.001

ACS

2525 (57.0)

3569 (62.2)

< 0.001

 UA/NSTEMI

1980 (44.7)

2776 (48.4)

< 0.001

 STEMI

545 (12.3)

793 (13.8)

0.025

Hemoglobin, g/dL

14.22 ± 1.57

14.36 ± 1.50

< 0.001

 Severe anemia (Hb<11 g/dL)

98 (2.2)

80 (1.4)

0.002

 Mild anemia (Hb: 11.0-12.9 g/dL for males or 11.0-11.9 g/dL for females)

461 (10.4)

479 (8.3)

< 0.001

Platelet count, 10⁹/L

204.63 ± 54.15

206.50 ± 56.27

0.090

 Platelet<100×10⁹/L

44 (1.0)

49 (0.9)

0.465

White blood cell count, 10⁹/L

6.81 ± 1.64

6.69 ± 1.71

0.001

PARIS thrombotic risk score

2.83 ± 1.82

2.27 ± 1.52

< 0.001

PARIS bleeding risk score

3.86 ± 2.20

3.59 ± 1.97

< 0.001

PRECISE-DAPT score

11.54 ± 9.25

9.85 ± 7.77

< 0.001

Oral anticoagulation therapy

6 (0.1)

12 (0.2)

0.381

Duration of DAPT, days

576.49 ± 207.78

562.37 ± 208.25

0.001